Clinical Trials Logo

Clinical Trial Summary

Epilepsy is a syndrome of episodic brain dysfunction characterized by recurrent seemingly unpredictable spontaneous seizures. The occurrence of the seizure in patients without any forewarning is the most debilitating aspect of the disease.

The Epicall system is intended for early detection of seizure related life threatening events by monitoring per-seizures biomarkers. The system is based on a sticker placed on the side of the face. The external sticker incorporates EOG (electrooculograph electrode) and PPG (photoplethysmograph electrode) sensors for continuous monitoring of:

1. Heart Rate (base line, increase, decrease, asystole).

2. Extra ocular eye movement (blinking, eye deviation, roving eye movements).


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01436695
Study type Observational
Source Epicall LTD
Contact Hanna Levy, Dr
Phone +972-4-638-8837
Email hanna@qsitemed.com
Status Not yet recruiting
Phase N/A
Start date November 2011

See also
  Status Clinical Trial Phase
Completed NCT00021866 - Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy N/A
Completed NCT01417507 - Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery N/A
Completed NCT01123746 - Utility of Laboratory Testing for Children With Seizure in Emergency Department N/A
Completed NCT02926703 - Lactate Compared to Creatine Kinase as Diagnostic Marker in Generalized Epileptic Seizure N/A
Completed NCT01796574 - Ketogenic Diet for Refractory Status Epilepticus N/A
Recruiting NCT05746624 - Procedural Motor Memory in Long COVID-19 N/A
Terminated NCT02883712 - Study of Predictors of Response to Anti Epilepsy in Epilepsy
Completed NCT00880204 - Evaluation of Essential Surgical Skills-Emergency Maternal and Child Health Training N/A
Enrolling by invitation NCT02694094 - Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy
Completed NCT02426047 - Medium Chain Triglycerides as an Adjunct to the Modified Atkins Diet for Women With Catamenial Epilepsy N/A
Completed NCT01744301 - Acid Suppressing Drug Seizure Epidemiology Study N/A
Completed NCT01834482 - Modified Atkins Diet Plus KetoCal for Adult Epilepsy N/A
Completed NCT00946751 - To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions Phase 1
Completed NCT01694524 - Nervous System Infections Among Patients With Febrile Seizure N/A
Terminated NCT01910129 - Neurostimulation to the Vagus Nerve for the Reduction in Frequency of Seizures Associated With Epilepsy N/A
Completed NCT00298532 - OPALS Pediatric Study N/A
Completed NCT01982812 - A Dose-Escalation, Safety and Feasibility Study of Enteral LVT for Seizure Control in Pediatric CM Phase 2
Completed NCT01660672 - Enteral Levetiracetam For Seizure Control In Pediatric Cerebral Malaria Phase 1/Phase 2
Completed NCT00285285 - Point of Care Device Use in the Pediatric Emergency Department N/A
Completed NCT01801072 - Seizure Prophylaxis in Aneurysm Repair Phase 4